These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 7691497)

  • 1. Drug therapy of renovascular hypertension.
    Rosenthal T
    Drugs; 1993 Jun; 45(6):895-909. PubMed ID: 7691497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.
    Deshmukh H; Barker E; Anbarasan T; Levin D; Bell S; Witham MD; George J
    Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe hypertension in a 14-year-old child: Successful blood pressure control with additive administration of captopril, an angiotensin-converting enzyme inhibitor, in a patient with bilateral renovascular hypertension.
    Zhang X; Xu Y; Chen X; Wang S; Li X; Yan X
    Clin Exp Hypertens; 2017; 39(7):587-591. PubMed ID: 28621587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension therapy in patients with renal artery stenosis].
    Vogt B; Maillard M; Burnier M
    Ther Umsch; 2012 May; 69(5):279-81. PubMed ID: 22547359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
    Alhadad A; Sterner G; Herlitz H
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2836-8, 2840. PubMed ID: 19967962
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal artery stenosis: a disease worth pursuing.
    Parker SC; Hannah A; Brooks M; Louis WJ; O'Callaghan CJ
    Med J Aust; 2001 Aug; 175(3):149-53. PubMed ID: 11548082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for renovascular hypertension.
    Spence JD
    Expert Opin Pharmacother; 2002 Apr; 3(4):411-6. PubMed ID: 11934344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension.
    Mimran A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S45-50. PubMed ID: 1382165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists.
    Picciotto G; Sargiotto A; Petrarulo M; Rabbia C; De Filippi PG; Roccatello D
    J Nucl Med; 2003 Oct; 44(10):1574-81. PubMed ID: 14530469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive drugs in renal failure.
    Albert FW
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S108-12. PubMed ID: 7898089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal thrombosis induced by angiotensin-converting enzyme inhibitors in patients with renovascular hypertension.
    Hannedouche T; Godin M; Fries D; Fillastre JP
    Nephron; 1991; 57(2):230-1. PubMed ID: 2020353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hypertension and massive proteinuria in a newborn with renal artery stenosis.
    Cachat F; Bogaru A; Micheli JL; Lepori D; Guignard JP
    Pediatr Nephrol; 2004 May; 19(5):544-6. PubMed ID: 14986083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function.
    Tillman DM; Adams FG; Gillen G; Morton JJ; Robertson JI
    Am J Cardiol; 1987 Apr; 59(10):133D-142D. PubMed ID: 3034022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Murray GD; Robertson JI
    Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1697-9. PubMed ID: 6293638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension.
    Hackam DG; Spence JD; Garg AX; Textor SC
    Hypertension; 2007 Dec; 50(6):998-1003. PubMed ID: 17923585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.